| Cat. No. |
Product Name / Activity |
| 4547 |
ACHP |
| Selective IKKα and IKKβ inhibitor; blocks NF-κB-DNA binding |
| 4857 |
Amlexanox |
| Inhibitor of TBK1 and IKKε; antiallergic agent |
| 1777 |
Arctigenin |
| Inhibitor of IκBα phosphorylation. Also inhibits MEK1 |
| 1743 |
Bay 11-7085 |
| Irreversible inhibitor of TNF-α-induced IκBα phosphorylation |
| 1744 |
Bay 11-7821 |
| Indirect inhibitor of IκBα phosphorylation |
| 4806 |
BMS 345541 |
| Selective allosteric inhibitor of IKK; anti-inflammatory |
| 5821 |
C-DIM 12 |
| Inhibits NF-κB-dependent gene expression; Nurr1 activator |
| 2743 |
Caffeic acid phenethyl ester |
| Specific inhibitor of NF-κB activation |
| 2509 |
Cardamonin |
| Inhibitor of NF-κB activation; anti-inflammatory |
| 3203 |
Celastrol |
| Inhibits TNF-α-induced NF-κB activation |
| 6237 |
FPS ZM1 |
| High affinity antagonist of the receptor for advanced glycation end products (RAGE) |
| 5672 |
GSK 319347A |
| Potent and selective IKKε inhibitor |
| 2539 |
IKK 16 |
| Selective inhibitor of IKK |
| 2611 |
IMD 0354 |
| Inhibitor of IKKβ |
| 5699 |
IP7e |
| Blocks NF-κB pathway; also potent Nurr1 activator |
| 2874 |
Luteolin |
| Blocks NF-κB activation |
| 1748 |
MG 132 |
| Inhibits NF-κB activation; proteasome and calpain inhibitor |
| 4899 |
ML 120B dihydrochloride |
| Novel IKK2-selective inhibitor |
| 7136 |
NIKi |
| Potent NIK inhibitor |
| 4238 |
PF 184 |
| Potent and selective IKKβ inhibitor |
| 1554 |
Piceatannol |
| Inhibits TNF-induced NF-κB activation |
| 6259 |
RAGE antagonist peptide |
| Receptor for advanced glycation end products (RAGE) antagonist |
| 5309 |
SP 100030 |
| NF-κB and AP-1 dual inhibitor |
| 4935 |
Sulfasalazine |
| Inhibitor of NF-κB activation; also inhibits SXC and folate transporter 1 |
| 2559 |
TPCA-1 |
| Potent, selective inhibitor of IKKβ |
| 2816 |
Withaferin A |
| Inhibits NF-κB activation |
| 6111 |
Zoledronic Acid |
| NF-κB signaling inhibitor; also potent farnesyl diphosphate (FPP) synthase inhibitor |